Essential fatty acid interactions
This article needs attention from an expert in Biology. Please add a reason or a talk parameter to this template to explain the issue with the article.(December 2022) |
This article's tone or style may not reflect the encyclopedic tone used on Wikipedia. (June 2021) |
There are many fatty acids found in nature. Two types of fatty acids considered essential for human health are the omega-3 and omega-6 types. These two essential fatty acids are necessary for some cellular signalling pathways and are involved in mediating inflammation, protein synthesis, and metabolic pathways in the human body.
Other dietary essential fatty acids are involved in inflammatory signalling and can oppose the impact of the arachidonic acid cascade. For example,
The diet from a century ago had much less ω-3 than the diet of early
Eicosanoid series nomenclature
Eicosanoids are signaling molecules derived from the essential fatty acids (EFAs). They are a major pathway by which the EFAs act in the body. There are four classes of eicosanoid and two or three series within each class.
The
After oxidation, the eicosanoids are further modified, making a series. Members of a series are differentiated by a letter and are numbered by the number of double bonds, which does not change within a series. For example, cyclooxygenase action upon AA (with 4 double bonds) leads to the series-2 thromboxanes[3] (TXA2, TXB2... ), each with two double bonds. Cyclooxygenase action on EPA (with 5 double bonds) leads to the series-3 thromboxanes (TXA3, TXB3, etc.), each with three double bonds. There are exceptions to this pattern, some of which indicate stereochemistry (PGF2α).
Table (1) shows these sequences for AA (20:4 ω-6). The sequences for
Dietary Essential Fatty Acid |
Abbreviation | Formula carbons: double bonds ω |
Eicosanoid product series | ||
---|---|---|---|---|---|
TX PG PGI |
LK | Effects | |||
Dihomo gamma linolenic acid
|
GLA DGLA |
18:3ω6 20:3ω6 |
series-1 | series-3 | less inflammatory |
Arachidonic acid | AA | 20:4ω6 | series-2 | series-4 | more inflammatory |
Eicosapentaenoic acid | EPA | 20:5ω3 | series-3 | series-5 | less inflammatory |
All prostanoids are substituted prostanoic acids. Cyberlipid Center's Prostenoid page[11] illustrates the parent compound and the rings associated with each series letter.
The IUPAC and the IUBMB use the equivalent term icosanoid.[11]
Arachidonic acid cascade in inflammation
In the arachidonic acid cascade, dietary
Mechanisms of ω-3 eicosanoid action
Eicosanoids from AA have been found to promote inflammation. Those from
Figure 2 shows the ω-3 and -6 synthesis chains, along with the major eicosanoids from AA, EPA, and DGLA.
Dietary ω-3 and GLA counter the inflammatory effects of AA's eicosanoids in three ways: displacement,
Displacement
Dietary ω-3 decreases tissue concentrations of AA.
Animal studies show that increased dietary ω-3 decreases AA in the brain and other tissues.
The reverse is true: high dietary linoleic acid decreases the body's conversion of α-linolenic acid to EPA. However, the effect is not as strong; the desaturase has a higher affinity for α-linolenic acid than it has for linoleic acid.[17]
Competitive Inhibition
DGLA and EPA compete with AA for access to the cyclooxygenase and lipoxygenase enzymes. So the presence of DGLA and EPA in tissues lowers the output of AA's
Counteraction
Some DGLA and EPA-derived eicosanoids counteract their AA-derived counterparts. For example, DGLA yields PGE1, which powerfully counteracts PGE2.[21] EPA yields the antiaggregatory prostacyclin PGI3 [22]. It also yields the leukotriene LTB5, which vitiates the action of the AA-derived LTB4.[23]
The paradox of dietary GLA
Studies have shown that dietary
DGLA inhibits inflammation through both competitive inhibition and direct counteraction (see above). Dietary GLA leads to sharply increased DGLA in the white blood cells' membranes, whereas LA does not. This may reflect white blood cells' lack of desaturase. Supplementing dietary GLA increases serum DGLA without increasing serum AA.[21][24]
It is likely that some dietary GLA eventually forms AA and contributes to inflammation. Animal studies indicate the effect is small.[19] The empirical observation of GLA's actual effects argues that DGLA's anti-inflammatory effects dominate.[25]
Complexity of pathways
Eicosanoid signaling paths are complex. It is therefore difficult to characterize the action of any particular eicosanoid. For example, PGE2 binds four receptors, dubbed EP1–4. Each is coded by a separate gene, and some exist in multiple
The arachidonic acid cascade in the Central Nervous System
The arachidonic acid cascade is arguably the most elaborate signaling system neurobiologists have to deal with.
Daniele Piomelli Arachidonic Acid[3]
The arachidonic acid cascade proceeds somewhat differently in the
The actions of eicosanoids within the brain are not as well characterized as they are in inflammation. Studies suggest that they act as second messengers within the neuron, possibly controlling presynaptic inhibition and the activation of protein kinase C. They also act as paracrine mediators, acting across synapses to nearby cells. The effects of these signals are not well understood. (Piomelli, 2000) states that there is little information available.
Neurons in the CNS are organized as interconnected groups of functionally related cells (e.g. in sensory systems). A diffusible factor released from a neuron into the
interstitial fluid, and able to interact with membrane receptors on adjacent cells would be ideally used to "synchronize" the activity of an ensemble of interconnected neural cells. Furthermore, during development and in certain forms of learning, postsynaptic cells may secrete regulatory factors that diffuse back to the presynaptic component, determining its survival as an active terminal, the amplitude of its sprouting, and its efficacy in secreting neurotransmitters—a phenomenon known as retrograde regulation. Studies have proposed that arachidonic acid metabolites participate in retrograde signaling and other forms of local modulation of neuronal activity.
Arachidonic Acid Cascade | ||
---|---|---|
In inflammation | In the brain | |
Major effect on | Inflammation in tissue | Neuronal excitability |
AA released from | White blood cells | Neurons |
Triggers for AA release | Inflammatory stimuli | Neurotransmitters, neurohormones and neuromodulators |
Intracellular effects on | DNA transcription of cytokines and other mediators of inflammation |
Activity of ion channels and protein kinases |
Metabolized to form | Eicosanoids, resolvins, isofurans, isoprostanes, lipoxins, epoxyeicosatrienoic acids (EETs) |
Eicosanoids, neuroprotectin D, EETs and some endocannabinoids |
The EPA and DGLA cascades are also present in the brain, and their eicosanoid metabolites have been detected. The effects of EPA and DGLA cascades on mental and neural processes are not as well characterized as their effects on inflammation.
Further discussion
Figure 2 shows two pathways from EPA to DHA, including the exceptional Sprecher's shunt.
5-LO acts at the fifth carbon from the carboxyl group. Other lipoxygenases—8-LO, 12-LO, and 15-LO—make other eicosanoid-like products. To act, 5-LO uses the nuclear-membrane
See also
- Essential fatty acid
- Omega-3 fatty acid
- Omega-6 fatty acid
- Fatty acid ratio in food
- Eicosanoid
- Docosanoid
References
- PMID 14559071.
- PMID 34776851.
- ^ a b c Piomelli, Daniele (2000). "Arachidonic Acid". Neuropsychopharmacology: The Fifth Generation of Progress. Archived from the original on 2006-07-15. Retrieved 2006-03-03.
- ISSN 1874-2947.)
{{cite journal}}
: CS1 maint: DOI inactive as of April 2024 (link - S2CID 40659630.
- PMID 29156608.
- PMID 11935953. Archived from the original (PDF) on 2006-09-26.)
{{cite book}}
:|journal=
ignored (help - ^ National Institute of Health (2005-08-01). "Omega-3 fatty acids, fish oil, alpha-linolenic acid". Archived from the original on February 8, 2006. Retrieved August 21, 2010.
- .
- ^ Cyberlipid Center. "Polyenoic fatty acids". Archived from the original on September 30, 2018. Retrieved February 11, 2006.
- ^ a b Cyberlipid Center. "Prostanoids". Archived from the original on February 8, 2007. Retrieved February 11, 2006.
- PMID 23674797.
- ^ a b Calder, Philip C. (September 2004). "n-3 Fatty Acids and Inflammation – New Twists in an Old Tale". Archived from the original on March 16, 2006. Retrieved February 8, 2006.
- Invited review article, PUFA Newsletter.
- ^ PMID 11435451.
- ^ Medical Study News (25 May 2005). "Brain fatty acid levels linked to depression". Retrieved February 10, 2006.
- Who were in turn citing Green P, Gispan-Herman I, Yadid G (June 2005). "Increased arachidonic acid concentration in the brain of Flinders Sensitive Line rats, an animal model of depression". Journal of Lipid Research. 46 (6): 1093–1096. PMID 15805551.
- Who were in turn citing Green P, Gispan-Herman I, Yadid G (June 2005). "Increased arachidonic acid concentration in the brain of Flinders Sensitive Line rats, an animal model of depression". Journal of Lipid Research. 46 (6): 1093–1096.
- ^ KP Su; SY Huang; CC Chiu; WW Shen (2003). "Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled?" (PDF). Archived from the original (PDF) on February 8, 2005. Retrieved February 22, 2006.
- PMID 2106775. Archived from the originalon February 12, 2007. Retrieved February 11, 2006.
- "[D]ietary arachidonic acid enriches its circulating pool in humans; however, 20:5n-3 is not similarly responsive to dietary restriction."
- PMID 7846101.
- GLA decreases triglycerides, LDL, increases HDL, decreases TXB2 and other inflammatory markers. Review article; human and rat studies.
- ^ S2CID 36538810.
- IV Supplementation with gamma-linolenic acid increased serum GLA but did not increase the plasma percentage of arachidonic acid (rat study), decreased TXB2.
- PMID 10617996.
- "DGLA itself cannot be converted to LTs but can form a 15-hydroxyl derivative that blocks the transformation of arachidonic acid to LTs. Increasing DGLA intake may allow DGLA to act as a competitive inhibitor of 2-series PGs and 4-series LTs and thus suppress inflammation."
- ^ PMID 9732298.
- "[D]ietary GLA increases the content of its elongase product, dihomo-gamma linolenic acid (DGLA), within cell membranes without concomitant changes in arachidonic acid (AA). Subsequently, upon stimulation, DGLA can be converted by inflammatory cells to 15-(S)-hydroxy-8,11,13-eicosatrienoic acid and prostaglandin E1. This is noteworthy because these compounds possess both anti-inflammatory and antiproliferative properties."
- PMID 2996649.
- PMID 6330066.
- PMID 9237935.
- S2CID 41372225.